Ge Nin Code Predictive Genetics
Biotechnology, 1400 16th St, Oxford, California, 94103, United States, 11-50 Employees
Phone Number: +18*********
Who is GENINCODE PREDICTIVE GENETICS
GENinCode specializes in risk assessment and prediction of cardiovascular disease , thrombosis and familial hypercholesterolemia . Cardiovascular disease (CVD) is a broad disease classifi...
Read More
![map](/x-assets/maps1.0-950f22e3512fa69a51fdf6612dcb593a74c2f8790b6e4ec5601cebb82b592ab9.png)
-
Headquarters: 1400 16th St, Oxford, California, 94103, United States
-
Date Founded: 2018
-
Employees: 11-50
-
Revenue: $250 Million to $500 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 7372
|
NAICS Code: 513210 |
Show More
Does something look wrong? Fix it. | View contact records from GENINCODE PREDICTIVE GENETICS
GENinCode Predictive Genetics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding GENinCode Predictive Genetics
Answer: GENinCode Predictive Genetics's headquarters are located at 1400 16th St, Oxford, California, 94103, United States
Answer: GENinCode Predictive Genetics's phone number is +18*********
Answer: GENinCode Predictive Genetics's official website is https://genincode.com
Answer: GENinCode Predictive Genetics's revenue is $250 Million to $500 Million
Answer: GENinCode Predictive Genetics's SIC: 7372
Answer: GENinCode Predictive Genetics's NAICS: 513210
Answer: GENinCode Predictive Genetics has 11-50 employees
Answer: GENinCode Predictive Genetics is in Biotechnology
Answer: GENinCode Predictive Genetics contact info: Phone number: +18********* Website: https://genincode.com
Answer: GENinCode specializes in risk assessment and prediction of cardiovascular disease , thrombosis and familial hypercholesterolemia . Cardiovascular disease (CVD) is a broad disease classification including coronary artery disease such as angina and myocardial infarction often referred to as heart attack. CVD also includes stroke, heart failure, hypertension and other vascular heart diseases and is the leading cause of death and disability worldwide accounting for 1 in every 4 deaths in the United States. GENinCode provides advanced genomic technology, products and recommendations fully validated by our scientific and clinical team. Our goal is to provide doctors and health care practitioners with advanced health information that combines both traditional clinical measures with a patients genetic information to provide a comprehensive risk assessment and clinical recommendation to help decision-making. Our technology helps select the optimal treatment pathway and informs and educates patients to become more aware of their cardiovascular risk helping patient adherence and empowerment to better manage their health. GENinCode technology and advanced genomic products provide information that helps patients and healthcare practitioners to assess and predict the onset of cardiovascular disease, thrombosis, and the diagnosis of Familial Hypercholesterolemia. Our online reporting system SITAB helps inform doctors of their patients health risk enabling patient behavioral and lifestyle changes alongside delivering the most effective therapies and treatment pathways.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month